Affinity Asset Advisors, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001773195

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallHealth TiltHigh Turnover how tags are computed

Q4 2024 · 81 positions · Total reported value $719.46M · Top-10 concentration 49.0% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 55.3% · 24 new · 29 cut · 20 exited

Active Share (vs S&P 500): 99.9% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -12.1% · vs SPY -14.3% · Prev Value $2.08B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): -2.2% · vs SPY -4.3% · Latest Value $2.15B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q4 2024 13F filing, Affinity Asset Advisors, LLC disclosed 81 equity positions with a combined reported value of $719.46M. The filing implies a moderately concentrated portfolio: its ten largest positions account for 49.0% of reported value. HoldingsHub classifies the profile as Small / Health Tilt / High Turnover.

The largest disclosed positions as of Q4 2024 were XBI ($67.55M), XENE ($45.52M), APGE ($42.21M). By sector, the heaviest allocations are Health Care 59.9%, Materials 0.5%. Versus the prior quarter, allocation shifted toward Other (+2.0pp) and away from Health Care (-2.6pp).

Versus the prior quarter, Affinity Asset Advisors, LLC opened 24 new positions, trimmed 29 and fully exited 20, a turnover rate of 55.3% of positions. The portfolio's overlap with the prior quarter was 63% of names.

The largest new positions opened in Q4 2024 were XBI ($67.55M), MESO ($16.60M), AMGN ($7.82M).

Of the 20 positions fully exited versus the prior quarter, the largest were KURA ($13.44M), ATXS ($7.98M), ONC ($7.86M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2024)

  • XBI SPDR SERIES TRUST · $67.55M
  • MESO MESOBLAST LTD · $16.60M
  • AMGN AMGEN INC · $7.82M
  • PRQR PROQR THRAPEUTICS N V · $7.49M
  • NMRA NEUMORA THERAPEUTICS INC. · $5.04M
  • PTGX PROTAGONIST THERAPEUTICS INC · $5.02M
  • CGON CG ONCOLOGY INC · $2.87M
  • OACCU OAKTREE ACQUISITION CORP III · $2.54M

Fully Exited (vs previous quarter)

  • KURA KURA ONCOLOGY INC · prev qtr: $13.44M
  • ATXS ASTRIA THERAPEUTICS INC · prev qtr: $7.98M
  • ONC BEONE MEDICINES LTD · prev qtr: $7.86M
  • ANAB ANAPTYSBIO INC · prev qtr: $6.70M
  • SPRY ARS PHARMACEUTICALS INC COM · prev qtr: $5.80M
  • TERN TERNS PHARMACEUTICALS INC · prev qtr: $5.00M
  • SWTX SPRINGWORKS THERAPEUTICS INC · prev qtr: $4.73M
  • NVAX NOVAVAX INC · prev qtr: $3.79M

Insider Transactions (Form 4)

Latest Affinity Asset Advisors, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Affinity Asset Advisors, LLC is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 108 US equity positions with a combined value of $2.08B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-120744 (status: Approved), registered 2021-04-09
  • Regulatory AUM (Form ADV): $2.45B as of 2026-07-27
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 2 private funds, of which 1 hedge funds
  • Website: affinityadv.com

Portfolio Structure

  • 108 positions · $2.08B reported value (Q2 2026)
  • Top 10 holdings = 41.7% of reported value
  • Largest position: ROIV (ROIVANT SCIENCES LTD) at 6.4%
  • Average position size: $19.25M

Sector Tilt

  • Health Care 87.6%
  • Financials 1.3%
  • Materials 0.3%
  • (classified holdings cover 89% of value)

Quarterly Activity

  • Q2 2026: 19 new, 34 added, 31 reduced, 12 exited
  • 24 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 59.9%
Materials 0.5%
Financials 0.4%
Other 39.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 750.00K $67.55M 9.39%
9.39%
New
2 1.16M $45.52M 6.33%
6.33%
Add
3 931.73K $42.21M 5.87%
5.87%
Add
4 425.00K $32.59M 4.53%
4.53%
Add
5 1.10M $31.64M 4.40%
4.40%
Add
6 1.40M $30.86M 4.29%
4.29%
Add
7 660.00K $30.65M 4.26%
4.26%
Add
8 82.50K $25.46M 3.54%
3.54%
Reduce
9 460.00K $23.52M 3.27%
3.27%
Add
10 285.00K $22.31M 3.10%
3.10%
Reduce
11 824.33K $19.19M 2.67%
2.67%
Add
12 1.50M $18.55M 2.58%
2.58%
Add
13 1.10M $18.36M 2.55%
2.55%
Add
14 425.00K $17.97M 2.50%
2.50%
Reduce
15 940.08K $17.71M 2.46%
2.46%
Add
16 838.60K $16.60M 2.31%
2.31%
New
17 389.24K $16.37M 2.27%
2.27%
Add
18 16.62M $16.19M 2.25%
2.25%
Hold
19 279.44K $12.87M 1.79%
1.79%
Reduce
20 630.00K $12.08M 1.68%
1.68%
Add
21 15.25M $11.87M 1.65%
1.65%
Add
22 3.97M $11.00M 1.53%
1.53%
Add
23 425.00K $10.92M 1.52%
1.52%
Reduce
24 4.50M $10.57M 1.47%
1.47%
Hold
25 2.25M $7.96M 1.11%
1.11%
Add
26 30.00K $7.82M 1.09%
1.09%
New
27 1.57M $7.72M 1.07%
1.07%
Reduce
28 2.83M $7.49M 1.04%
1.04%
New
29 368.70K $7.15M 0.99%
0.99%
Add
30 75.00K $6.35M 0.88%
0.88%
Reduce
31 2.50M $6.27M 0.87%
0.87%
Hold
32 300.00K $5.64M 0.78%
0.78%
Reduce
33 200.00K $5.49M 0.76%
0.76%
Reduce
34 475.00K $5.04M 0.70%
0.70%
New
35 130.00K $5.02M 0.70%
0.70%
New
36 350.00K $4.31M 0.60%
0.60%
Hold
37 1.30M $4.15M 0.58%
0.58%
Add
38 1.74M $4.10M 0.57%
0.57%
Add
39 550.76K $4.09M 0.57%
0.57%
Add
40 350.00K $3.56M 0.49%
0.49%
Hold
41 200.00K $3.48M 0.48%
0.48%
Reduce
42 50.00K $3.45M 0.48%
0.48%
Hold
43 237.94K $3.33M 0.46%
0.46%
Add
44 850.51K $3.21M 0.45%
0.45%
Add
45 2.49M $3.21M 0.45%
0.45%
Add
46 263.82K $3.21M 0.45%
0.45%
Hold
47 159.61K $3.06M 0.42%
0.42%
Reduce
48 70.74K $2.93M 0.41%
0.41%
Reduce
49 100.00K $2.87M 0.40%
0.40%
New
50 58.33K $2.69M 0.37%
0.37%
Hold

FAQ

What did Affinity Asset Advisors, LLC buy in 2024-Q4?

In its 2024-Q4 13F filing, Affinity Asset Advisors, LLC reported 81 equity positions worth $719.46M in aggregate; its largest disclosed positions were XBI ($67.55M), XENE ($45.52M), APGE ($42.21M).

How large is Affinity Asset Advisors, LLC's portfolio?

Affinity Asset Advisors, LLC reported $719.46M of long equity holdings across 81 positions as of 2024-Q4. Top-10 holdings account for 49.0% of reported value.

What is Affinity Asset Advisors, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/affinity-asset-advisors/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →